Your browser doesn't support javascript.
loading
The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit.
Clipson, Alexandra; Barrans, Sharon; Zeng, Naiyan; Crouch, Simon; Grigoropoulos, Nicholas F; Liu, Hongxiang; Kocialkowski, Sylvia; Wang, Ming; Huang, Yuanxue; Worrillow, Lisa; Goodlad, John; Buxton, Jenny; Neat, Michael; Fields, Paul; Wilkins, Bridget; Grant, John W; Wright, Penny; Ei-Daly, Hesham; Follows, George A; Roman, Eve; Watkins, A James; Johnson, Peter W M; Jack, Andrew; Du, Ming-Qing.
Afiliação
  • Clipson A; Division of Molecular Histopathology Department of Pathology University of Cambridge UK.
  • Barrans S; Haematological Malignancy Diagnostic Service St. James's Institute of Oncology Leeds UK.
  • Zeng N; Division of Molecular Histopathology Department of Pathology University of Cambridge UK.
  • Crouch S; Department of Health Sciences Epidemiology and Cancer Statistics Group University of York York UK.
  • Grigoropoulos NF; Division of Molecular HistopathologyDepartment of PathologyUniversity of CambridgeUK; Department of HaematologyAddenbrooke's Hospital, Cambridge University Hospitals NHS Foundation TrustCambridgeUK.
  • Liu H; Department of Histopathology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
  • Kocialkowski S; Division of Molecular Histopathology Department of Pathology University of Cambridge UK.
  • Wang M; Division of Molecular Histopathology Department of Pathology University of Cambridge UK.
  • Huang Y; Division of Molecular Histopathology Department of Pathology University of Cambridge UK.
  • Worrillow L; Haematological Malignancy Diagnostic Service St. James's Institute of Oncology Leeds UK.
  • Goodlad J; Department of Pathology Western General Hospital Edinburgh UK.
  • Buxton J; Department of Haematology Western General Hospital Edinburgh UK.
  • Neat M; Department of Haematology and Department of Cytogenetics GSTS Pathology Guy's and St. Thomas NHS Foundation Trust London UK.
  • Fields P; Department of Haematology GSST Kings Health Partners London UK.
  • Wilkins B; Histopathology Department St Thomas' Hospital and King's College London UK.
  • Grant JW; Department of Histopathology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
  • Wright P; Department of Histopathology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
  • Ei-Daly H; Department of Haematology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
  • Follows GA; Department of Haematology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
  • Roman E; Department of Health Sciences Epidemiology and Cancer Statistics Group University of York York UK.
  • Watkins AJ; Department of Haematology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
  • Johnson PW; Cancer Research UK Centre University of Southampton Southampton United Kingdom.
  • Jack A; Haematological Malignancy Diagnostic Service St. James's Institute of Oncology Leeds UK.
  • Du MQ; Division of Molecular HistopathologyDepartment of PathologyUniversity of CambridgeUK; Department of HistopathologyAddenbrooke's Hospital, Cambridge University Hospitals NHS Foundation TrustCambridgeUK.
J Pathol Clin Res ; 1(3): 125-133, 2015 Jul.
Article em En | MEDLINE | ID: mdl-27347428
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Pathol Clin Res Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Pathol Clin Res Ano de publicação: 2015 Tipo de documento: Article